EUVIMEDEUVIMED entdecken
Crossref

Urinary levels of kidney injury molecule-1 (KIM-1) and interleukin-18 (IL-18) in children and adolescents with hyperuricemia

Monika Kamianowska, Aleksandra Kamianowska, Anna Wasilewska

Advances in Medical Sciences · 2023

DOI: 10.1016/j.advms.2023.01.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Medical Sciences, 2023. Verfasst von Monika Kamianowska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology and Neonatal Intensive Care, Medical University of Bialystok, Bialystok, Poland. Electronic address: monika.kamianowska@umb…. Hauptthemen laut MEDLINE: Hyperuricemia, Kidney Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Uniwersytet Medyczny w Bialymstoku.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Hyperuricemia may lead to silent tissue damage and increase the risk of some diseases, including kidney diseases. Increased serum uric acid concentration induces inflammatory pathways and promotes kidney damage. This study aimed to determine whether hyperuricemia influences the levels of urinary kidney injury markers in children and adolescents with hyperuricemia, assessed by the urinary concentrations of interleukin-18, a biomarker of inflammation, and kidney injury molecule-1 (KIM-1), a biomarker of kidney injury. MATERIAL AND METHODS: The study included 73 children and adolescents (32 males and 41 females) aged 2-18 years. They were divided into two groups: hyperuricemia (HU) group (n ​= ​48) and normouricemia - reference group (R) (n ​= ​25). The concentrations of urinary interleukin-18 and KIM-1 were measured using an ELISA kit and were normalized for urinary creatinine (cr.) concentration. RESULTS: The median interleukin-18/cr. Levels in the HU group were significantly higher than in the R group (median, Q1-Q3) 21.83 (11.32-35.96) and 12.68 (7.11-24.04), respectively, (p ​< ​0.05). The KIM-1/cr. in the HU group and the R group were (median, Q1-Q3) 0.79 (0.45-1.03) and 0.81 (0.59-1.01), respectively, and the difference was not significant. KIM-1/cr. did not differ between the groups. Interleukin-18/cr. ratio correlated positively with serum uric acid concentration (r ​= ​0.24, p ​< ​0.05). CONCLUSIONS: Interleukin-18/cr., but not KIM-1/cr. was higher in children with hyperuricemia. Hyperuricemia results in increased IL-18 in urine, in absence of other markers of kidney injury, suggesting inflammation in the kidney. Additional studies on the adults should be done, to confirm this hypothesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaKidney DiseasesMaleAdultFemaleHumansChildAdolescentInterleukin-18Uric AcidHepatitis A Virus Cellular Receptor 1KidneyBiomarkersInflammation

Stichwörter der Autor:innen

Children and adolescentsHyperuricemiaInterleukin-18 (IL-18)Kidney injury molecule-1 (KIM-1)

Substanzen

Interleukin-18Uric AcidHepatitis A Virus Cellular Receptor 1Biomarkers

Autor:innen und Institutionen

  • Department of Neonatology and Neonatal Intensive Care, Medical University of Bialystok, Bialystok, Poland. Electronic address: monika.kamianowska@umb.edu.pl.
  • Department of Pediatrics and Nephrology, Medical University of Bialystok, Bialystok, Poland.

Förderung

  • Uniwersytet Medyczny w Bialymstoku

Zitieren

APA

Kamianowska, M., Kamianowska, A., & Wasilewska, A. (2023). Urinary levels of kidney injury molecule-1 (KIM-1) and interleukin-18 (IL-18) in children and adolescents with hyperuricemia. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2023.01.004

Vancouver

Kamianowska M, Kamianowska A, Wasilewska A. Urinary levels of kidney injury molecule-1 (KIM-1) and interleukin-18 (IL-18) in children and adolescents with hyperuricemia. Advances in Medical Sciences. 2023. doi:10.1016/j.advms.2023.01.004

BibTeX
@article{Kamianowska2023,
  author = {Kamianowska, Monika and Kamianowska, Aleksandra and Wasilewska, Anna},
  title = {Urinary levels of kidney injury molecule-1 (KIM-1) and interleukin-18 (IL-18) in children and adolescents with hyperuricemia},
  journal = {Advances in Medical Sciences},
  year = {2023},
  doi = {10.1016/j.advms.2023.01.004}
}
Kostenlos starten →